Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Citi
Cipla
AstraZeneca
US Department of Justice
Medtronic
Harvard Business School
Teva

Generated: July 17, 2018

DrugPatentWatch Database Preview

Famciclovir - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for famciclovir and what is the scope of famciclovir freedom to operate?

Famciclovir
is the generic ingredient in two branded drugs marketed by Apotex, Aurobindo Pharma Ltd, Cipla Ltd, Hetero Labs Ltd V, Macleods Pharms Ltd, Mylan, Teva Pharms, West-ward Pharms Int, and Novartis, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for famciclovir. Nineteen suppliers are listed for this compound.

US Patents and Regulatory Information for famciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex FAMCICLOVIR famciclovir TABLET;ORAL 091480-002 Jul 22, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hetero Labs Ltd V FAMCICLOVIR famciclovir TABLET;ORAL 202438-002 Sep 10, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan FAMCICLOVIR famciclovir TABLET;ORAL 201333-003 Mar 24, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cipla Ltd FAMCICLOVIR famciclovir TABLET;ORAL 078278-001 Mar 21, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for famciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis FAMVIR famciclovir TABLET;ORAL 020363-002 Jun 29, 1994 ➤ Sign Up ➤ Sign Up
Novartis FAMVIR famciclovir TABLET;ORAL 020363-003 Dec 11, 1995 ➤ Sign Up ➤ Sign Up
Novartis FAMVIR famciclovir TABLET;ORAL 020363-001 Apr 26, 1996 ➤ Sign Up ➤ Sign Up
Novartis FAMVIR famciclovir TABLET;ORAL 020363-003 Dec 11, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
Citi
Accenture
Argus Health
Daiichi Sankyo
Baxter
Cantor Fitzgerald
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.